EX-99.1 2 tm236600d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Company Contact: Investor Relations Contact:  
Mr. Thomas Sammons Hayden IR  
Chief Financial Officer Brett Maas  
TechPrecision Corporation Phone: 646-536-7331  
Phone: 978-883-5109 Email: brett@haydenir.com  
Email: sammonst@ranor.com Website: www.haydenir.com  
Website: www.techprecision.com    

 

FOR IMMEDIATE RELEASE

 

TechPrecision Corporation Reports Third Quarter Fiscal 2023 Financial Results

Improving operating performance drives revenue growth and gross profit

 

Westminster, MA – February 14, 2023 – TechPrecision Corporation (OTCQB: TPCS) (“TechPrecision” or “the Company”), an industry-leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems with customers in the defense and precision industrial sectors, today reported financial results for the third quarter of fiscal year 2023 ended December 31, 2022.

 

“Third quarter consolidated net sales were $8.3 million or 28% higher when compared to $6.5 million in same quarter a year ago,” stated Alexander Shen, TechPrecision’s Chief Executive Officer. “Our Ranor segment reported a strong third quarter with net sales of $4.7 million and gross profit of $1.7 million. Our third quarter net sales included $3.6 million from our Stadco subsidiary. Gross profit and gross margin also significantly improved year-over-year for both the quarter and year-to-date periods.”

 

“We continue to make progress rebuilding Stadco manufacturing and throughput,” Mr. Shen continued. “We will continue at Stadco to focus on shepherding cash, rebuilding customer and supplier relationships, establishing operational discipline, improving gross margins, and growing the backlog. Total backlog remained strong at $43.9 million as of December 31, 2022. We expect to deliver that backlog over the course of the next one to three fiscal years with revenue growth and gross margin expansion.”

 

As to our applications to uplist to NASDAQ and for the reverse split, both have been filed and are pending with the appropriate entities, although there can be no assurance that our listing application with NASDAQ and our authorization to effect the reverse stock split will be approved by the appropriate entities in a timely manner or at all.

 

The following summary compares the three and nine months ended December 31, 2022 to the same prior year periods:

 

Fiscal 2023 Third Quarter Consolidated Financial Results 

 

· Net sales were $8.3 million, an increase of 28%, due to strong revenue growth at Ranor.
· Cost of sales were $6.8 million, or 13% higher, due primarily to increased net sales at Ranor and higher unabsorbed overhead at Stadco.
· Gross profit was $1.5 million, or $1.0 million higher when compared to the same quarter last year. Gross margin percentage was higher primarily due to a profitable project mix and strong throughput at Ranor.
· SG&A was $1.2 million, a year-over-year decrease of $0.4 million. Prior period SG&A included one-time costs for legal, accounting, and other outside advisory services related to the Stadco acquisition.
· Operating income was $0.3 million, compared to operating loss of $1.1 million in the same quarter a year ago.

 

Fiscal 2023 Nine Months Ended December 31, 2022 Consolidated Financial Results 

 

· Net sales were $23.9 million, an increase of $9.2 million or 63% when compared to the same nine-month period in the prior year. A profitable project mix of repeat business at Ranor plus twenty-one weeks of additional activity at Stadco were the drivers behind the revenue growth.
· Cost of sales were $19.9 million, or 59% higher, due to the increase in net sales for both Ranor and Stadco.
· Gross profit was $4.1 million, or 81% higher when compared to the same period last year. Gross margin percentage was higher because of a profitable production mix and better operating throughput.
· SG&A was $4.4 million, an increase of $0.9 million, primarily due to the added Stadco SG&A. The same period a year ago only included eighteen weeks of business activity at Stadco.
· Operating loss was $0.4 million, compared to operating loss of $1.3 million in the same period a year ago.

 

 

Financial Position

 

On December 31, 2022, TechPrecision had $0.3 million in cash and cash equivalents, a decrease since March 31, 2021. Working capital was $7.2 million at December 31, 2022 compared to $2.8 million at March 31, 2021 as we extended the Ranor term loan for an additional five years in December and converted a significant current liability to long-term. Total debt at December 31, 2022 and March 31, 2022 was $7.1 million and $7.4 million, respectively. In December 2022, our revolver loan was renewed for one year.

        

About TechPrecision Corporation

 

TechPrecision Corporation, through its wholly owned subsidiaries, Ranor, Inc. and Stadco, manufactures large-scale, metal fabricated and machined precision components and equipment. These products are used in a variety of markets including: defense, aerospace, nuclear, industrial, and medical. TechPrecision's goal is to be an end-to-end service provider to its customers by furnishing customized solutions for completed products requiring custom fabrication and machining, assembly, inspection and testing. To learn more about the Company, please visit the corporate website at http://www.techprecision.com. Information on the Company's website or any other website does not constitute a part of this press release.

 

Safe Harbor Statement

 

This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary companies. All statements other than statements of current or historical fact contained in this press release, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “prospects,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from: our reliance on individual purchase orders, rather than long-term contracts, to generate revenue; our ability to change the composition of our revenues and effectively control operating expenses; external factors that may be outside our control, including the COVID-19 pandemic, the Russia- Ukraine conflict, price inflation, interest rate increases and supply chain inefficiencies; the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto; the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity; our ability to receive contract awards through competitive bidding processes; our ability to maintain standards to enable us to manufacture products to exacting specifications; our ability to enter new markets for our services; our reliance on a small number of customers for a significant percentage of our business; competitive pressures in the markets we serve; changes in the availability or cost of raw materials and energy for our production facilities; restrictions in our ability to operate our business due to our outstanding indebtedness; government regulations and requirements; pricing and business development difficulties; changes in government spending on national defense; our ability to make acquisitions and successfully integrate those acquisitions with our business; our failure to maintain effective internal controls over financial reporting; general industry and market conditions and growth rates; unexpected costs, charges or expenses resulting from the recently completed acquisition of Stadco; and other risks discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this press release, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

 

-- Tables Follow –

 

 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

 

  

December 31,

2022

  

March 31,

2022

 
ASSETS          
Current assets:          
Cash and cash equivalents  $316,185   $1,052,139 
Accounts receivable   2,927,407    3,009,249 
Contract assets   9,356,242    8,350,231 
Raw materials   1,271,558    874,538 
Work-in-process   1,020,566    1,360,137 
Other current assets   986,024    1,421,459 
Total current assets   15,877,982    16,067,753 
Property, plant and equipment, net   12,640,077    13,153,165 
Right of use asset, net   6,043,056    6,383,615 
Deferred income taxes   2,117,985    2,126,770 
Other noncurrent assets, net   726,456    121,256 
Total assets  $37,405,556   $37,852,559 
LIABILITIES AND STOCKHOLDERS’ EQUITY:          
Current liabilities:          
Accounts payable  $1,489,972   $3,426,921 
Accrued expenses   2,443,285    3,435,866 
Contract liabilities   1,905,262    1,765,319 
Current portion of long-term lease liability   727,803    593,808 
Current portion of long-term debt   2,069,859    4,093,079 
Total current liabilities   8,636,181    13,314,993 
Long-term debt, net   4,863,602    3,114,936 
Long-term lease liability   5,481,895    5,853,791 
Other noncurrent liabilities   2,828,737    305,071 
Total liabilities   21,810,415    22,588,791 
Commitments and contingencies - see Note 15          
Stockholders’ Equity:          
Common stock - par value $.0001 per share, 90,000,000 shares authorized, shares
issued and outstanding: December 31, 2022 – 34,443,959; March 31, 2022 - 34,307,450
   3,444    3,430 
Additional paid in capital   14,945,376    14,637,771 
Retained earnings   646,321    622,567 
Total stockholders’ equity   15,595,141    15,263,768 
Total liabilities and stockholders’ equity  $37,405,556   $37,852,559 

 

 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME (LOSS)

(unaudited)

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2022   2021   2022   2021 
Net sales  $8,327,345   $6,511,325   $23,926,349   $14,720,964 
Cost of sales   6,828,458    6,033,267    19,870,572    12,479,531 
Gross profit   1,498,887    478,058    4,055,777    2,241,433 
Selling, general and administrative   1,224,572    1,623,883    4,426,894    3,530,179 
Income (loss) from operations   274,315    (1,145,825)   (371,117)   (1,288,746)
  Other income   254    1,999    40,590    13,390 
  Interest expense   (93,603)   (94,721)   (260,978)   (181,494)
  PPP loan forgiveness   --    --    --    1,317,100 
  Refundable employee retention tax credits   --    --    624,045    -- 
Total other (expense) income   (93,349)   (92,722)   403,657    1,148,996 
Income (loss) before income taxes   180,966    (1,238,547)   32,540    (139,750)
Income tax expense (benefit)   46,991    (333,867)   8,786    (385,749)
Net income (loss)  $133,975   $(904,680)  $23,754   $245,999 
Other comprehensive loss:                    
  Foreign currency translation adjustments  $--   $(810)  $--   $(1,909)
Other comprehensive loss  $--   $(810)  $--   $(1,909)
Comprehensive income (loss)  $133,975   $(905,490)  $23,754   $244,090 
Net income (loss) per share basic  $0.00   $(0.03)  $0.00   $0.01 
Net income (loss) per share diluted  $0.00   $(0.03)  $0.00   $0.01 
Weighted average shares outstanding - basic   34,443,959    34,286,580    34,363,352    31,716,353 
Weighted average shares outstanding - diluted   36,134,709    34,286,580    36,039,468    33,395,123 

 

 

TECHPRECISION CORPORATION

NET SALES, COST OF SALES, GROSS PROFIT BY SEGMENT

(unaudited)

 

  

Three Months ended

December 31, 2022

  

Three Months ended

December 31, 2021

   Changes 
(dollars in thousands)  Amount  

Percent of

net sales

   Amount  

Percent of

net sales

   Amount   Percent 
Ranor  $4,735    57%  $2,790    43%  $1,945    70%
Stadco   3,592    43%   3,721    57%   (129)   (3)%
Net sales  $8,327    100%  $6,511    100%  $1,816    28%
Ranor  $3,056    37%  $2,538    39%  $518    20%
Stadco   3,773    45%   3,495    54%   278    8%
Cost of sales  $6,828    82%  $6,033    93%  $795    13%
Ranor  $1,680    20%  $199    3%  $1,481    744%
Stadco   (181)   (2)%   279    4%   (460)   (165)%
Gross profit  $1,499    18%  $478    7%  $1,021    214%

 

  

Nine Months ended

December 31, 2022

  

Nine Months ended

December 31, 2021

   Changes 
(dollars in thousands)  Amount  

Percent of

net sales

   Amount  

Percent of

net sales

   Amount   Percent 
Ranor  $14,395    60%  $9,741    66%  $4,654    48%
Stadco   9,531    40%   4,980    34%   4,551    91%
Net sales  $23,926    100%  $14,721    100%  $9,205    63%
Ranor  $8,849    37%  $7,924    54%  $925    12%
Stadco   11,022    46%   4,556    31%   6,466    142%
Cost of sales  $19,871    83%  $12,480    85%  $7,391    59%
Ranor  $5,546    23%  $1,764    12%  $3,782    214%
Stadco   (1,491)   (6)%   477    3%   (1,968)   nm%
Gross profit  $4,055    17%  $2,241    15%  $1,814    81%

 

 

TECHPRECISION CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   Nine Months Ended
December 31,
 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income  $23,754   $245,999 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
 Depreciation and amortization   1,666,741    978,517 
 Amortization of debt issue costs   39,961    34,588 
 Stock based compensation expense   307,619    141,176 
 Change in contract loss provision   100,880    (66,232)
 Deferred income taxes   8,785    (386,413)
 PPP loan forgiveness   --    (1,317,100)
 Change in fair value for contingent consideration   63,436    -- 
 Gain on sale of fixed asset   (468)   -- 
Changes in operating assets and liabilities:          
 Accounts receivable   81,842    (575,181)
 Contract assets   (1,006,010)   (871,339)
 Work-in-process and raw materials   (57,450)   477,936 
 Other current assets   435,435    215,334 
 Other noncurrent assets   --    (50,633)
 Accounts payable   (166,749)   (611,045)
 Accrued expenses   (1,741,606)   (1,282,269)
 Contract liabilities   139,944    1,418,010 
 Other noncurrent liabilities   974,737    -- 
Net cash provided by (used in) operating activities   870,851    (1,648,652)
CASH FLOWS FROM INVESTING ACTIVITIES:          
 Business acquisition, net of cash acquired   --    (7,795,810)
 Proceeds from sale of fixed assets   7,000    -- 
 Fixed asset deposit   (605,200)   -- 
 Purchases of property, plant, and equipment   (663,033)   (436,531)
Net cash used in investing activities   (1,261,233)   (8,232,341)
CASH FLOWS FROM FINANCING ACTIVITIES:          
 Proceeds from term loan   --    4,000,000 
 Closing costs related to common stock sale   --    (335,419)
 Proceeds from sale of common stock   --    3,523,000 
 Debt issue costs   (43,945)   (116,511)
 Revolver loan payments and borrowings, net   187,998    1,978,221 
 Payments of principal for leases   (31,058)   (493,015)
 Repayments of long-term debt   (458,567)   (243,510)
Net cash (used in) provided by financing activities   (345,572)   8,312,766 
Effect of exchange rate on cash and cash equivalents   --    (25)
Net decrease in cash and cash equivalents   (735,954)   (1,568,252)
Cash and cash equivalents, beginning of period   1,052,139    2,130,711 
Cash and cash equivalents, end of period  $316,185   $562,459 

 

 

TECHPRECISION CORPORATION

SUPPLEMENTAL INFORMATION

Reconciliation of EBITDA to Net Income (Loss)

 

The following table provides a reconciliation of EBITDA to net income (loss), the most directly comparable U.S. GAAP measure reported in our condensed consolidated financial statements for the following periods:

 

   Three Months ended December 31,   Nine Months ended December 31, 
(dollars in thousands)  2022   2021   Change   2022   2021   Change 
Net income (loss)  $134   $(905)  $1,039   $24   $246   $(222)
Income tax expense (benefit)   47    (334)   381    9    (386)   395 
Interest expense (1)   94    95    (1)   261    181    80 
Depreciation and amortization   550    463    87    1,667    979    688 
EBITDA  $825   $(681)  $1,506   $1,961   $1,020   $941 

 

  (1) Includes amortization of debt issue costs.

 

#